Literature DB >> 16698196

[Biological diagnosis of systemic candidiasis: difficulties and future prospects].

S Anane1, F Khalfallah.   

Abstract

The diagnosis of systemic Candidiasis is difficult to establish and biologic diagnosis raises problems. Blood culture which is the gold standard for the diagnosis of systemic Candidiasis lacks sensitivity and usually takes several days to become positive. Early diagnostic approach is imperative to avoid delays in the initiation for treatment. Therefore, nonculture methods like test for Candida antigen detection, metabolite detection or Candida DNA detection by PCR are being developed for the laboratory diagnosis. Candida derived metabolites and antigens detection lacks sensitivity. A new strategy consisting of the combined detection of mannanemia and an antibody response was developed. The combined detection has a high specificity and sensitivity in the diagnosis of invasive candidiasis. The results of tests for the detection of yeast DNA by PCR obtained recently are promising in terms of sensitivity, specificity and identification of species of Candida.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16698196     DOI: 10.1016/j.patbio.2006.03.003

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  3 in total

1.  High-throughput identification and quantification of Candida species using high resolution derivative melt analysis of panfungal amplicons.

Authors:  Tasneem Mandviwala; Rupali Shinde; Apoorv Kalra; Jack D Sobel; Robert A Akins
Journal:  J Mol Diagn       Date:  2009-12-10       Impact factor: 5.568

Review 2.  Use of recombinant antigens for the diagnosis of invasive candidiasis.

Authors:  Ana Laín; Natalia Elguezabal; Elena Amutio; Iñigo Fernández de Larrinoa; María Dolores Moragues; José Pontón
Journal:  Clin Dev Immunol       Date:  2008

3.  A Real Time PCR strategy for the detection and quantification of Candida albicans in human blood.

Authors:  Felipe Delatorre Busser; Vivian Caso Coelho; Claudia de Abreu Fonseca; Gilda Maria Barbaro Del Negro; Maria Aparecida Shikanai-Yasuda; Marta Heloisa Lopes; Marcello Mihailenko Chaves Magri; Vera Lucia Teixeira de Freitas
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2020-02-07       Impact factor: 1.846

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.